Australia 200

CSL, Resmed, Ramsay and Sonic Healthcare, are they in the buy zone? | Switzer Investing



Listen to the audio version here: https://pnc.st/s/switzer-property/a4ab48e1/csl-resmed-ramsay-and-sonic-healthcare-are-they-in-the-buy-zone-switzer-investing

Timecode-
00:00 Intro
01:19 Peter and Paul discuss if Healthcare will shine?
10:21 Raymond Chan
22:06 Marcus Bogdan
33:21 Outro

Subscribe to Switzer:
Switzer Report – https://switzersuperreport.com.au/subscribe
Switzer Daily – https://switzer.com.au/subscribe
The Peter Switzer Show – https://switzer.com.au/the-peter-switzer-show/

Follow Switzer:
YouTube – https://youtube.com/channel/UCbzy75ul0j64m2s_L–i1gA?sub_confirmation=1
Facebook – https://facebook.com/switzer.com.au/
Twitter – https://twitter.com/switzercomau
LinkedIn – https://linkedin.com/company/switzer-media—publishing

#asx #sharemarket #stocks

source

Related Articles

8 Comments

  1. I can never understand why CSL is held in high regard and as a growth stock. Its closing price today is $293.33, on a P/E of 41. It first hit that price on January 10th 2020. Earning in that year $6.72, last year $7.35, so about 10% growth over two year, or 5%pc pa. The dividend now is 1.2% pa partially franked. Why would you hold it?

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button